BROWSE·page 575 of 600

Browse EX-10 agreements

7,199 total material contract exhibits.


EX-10.3

EX-10.3

Exhibit 10.3

FIRST AMENDMENT TO REGISTRATION RIGHTS AGREEMENT

This FIRST AMENDMENT TO THE REGISTRATION RIGHTS AGREEMENT (THIS “AMENDMENT”), is made and effective as of May 11, 2026, by and among Black Titan Corporation, a Cayman Islands exempted company (the “Company”), and the holder of registration rights under the Registration Rights Agreement (defined below) signatory hereto (the “Holder”).

RECITALS

WHEREAS, on January 16, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”), by and between the Company and the Holder, pursuant to which the Holder purchased a Senior Unsecured Convertible Note (the “Note”) from the Company upon the terms and conditions set forth in the Purchase Agreement and the Note;

WHEREAS, on January 16, 2026, the Company agreed to provide certain registration rights with respect to the Registrable Securities (as defined in the Registration Rights Agreement) to the Holder pursuant to that certain Registration Rights Agreement, dated as of January 16, 2026 (the “Registration Rights Agreement”);

EX-10.3·6-K·CIK 2034400·ACC 0001493152-26-023895·Filed May 17, 2026, 15:01 EDT

EX-10.2

EX-10.2

Exhibit 10.2

FIRST AMENDMENT TO BLACK TITAN CORPORATION

SECURITIES PURCHASE AGREEMENT

This FIRST AMENDMENT TO THE BLACK TITAN CORPORATION SECURITIES PURCHASE AGREEMENT (THIS “AMENDMENT”), is made and effective as of May 11, 2026 (“Effective Date”), by and among Black Titan Corporation, a Cayman Islands exempted company (the “Company”), and the signatory hereto (the “Holder”).

RECITALS

WHEREAS, on January 16, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”), by and between the Company and the Holder, pursuant to which the Holder purchased a Senior Unsecured Convertible Note (the “Note”) from the Company upon the terms and conditions set forth in the Purchase Agreement and the Note;

WHEREAS, pursuant to Section 1(e) of the Purchase Agreement, the Holder may purchase at Additional Closings Additional Notes substantially in the form of Exhibit A to the Purchase Agreement;

EX-10.2·6-K·CIK 2034400·ACC 0001493152-26-023895·Filed May 17, 2026, 15:01 EDT

EX-10.1

EX-10.1

Exhibit 10.1

SETTLEMENT AND RELEASE AGREEMENT

This SETTLEMENT AND RELEASE AGREEMENT (“Agreement”), dated as of April 2, 2026, is entered into by and between Black Titan Corporation, as successor to Titan Pharmaceuticals, Inc. (the “Company”) and David Lazar (“Lazar,” together with the Company, the “Parties” and, each, a “Party”).

WHEREAS, the Parties entered into a certain Settlement Agreement and General Mutual Release dated April 2 (without a year) (the “Prior Settlement Agreement”);

WHEREAS, a dispute has arisen between the Parties regarding Lazar’s entitlement to the Special Bonus referenced in Section 1.b of the Prior Settlement Agreement (the “Special Bonus”); and

WHEREAS, the Parties have agreed to resolve their dispute regarding the Special Bonus pursuant to the terms and conditions of this Agreement;

NOW, THEREFORE, in consideration of the mutual promises and obligations herein, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:

EX-10.1·6-K·CIK 2034400·ACC 0001493152-26-023895·Filed May 17, 2026, 15:01 EDT

EX-10.14

EX-10.14

EXECUTION VERSION

SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of May 1, 2026 (the “Amendment Date”), among ASP BDC LEV FACILITATION LLC, a Delaware limited liability company, as the borrower (the “Borrower”), ADAMS STREET CREDIT SOLUTIONS FUND, a Delaware statutory trust, as the servicer (in such capacity, the “Servicer”), the equityholder (in such capacity, the “Equityholder”) and the seller (in such capacity, the “Seller”), WELLS FARGO BANK, NATIONAL ASSOCIATION, as the administrative agent (in such capacity, the “Administrative Agent”), each of the lenders from time to time party to the Loan and Security Agreement (as defined below) (together with their respective successors and assigns in such capacity, each a “Lender,” and collectively, the “Lenders”) and COMPUTERSHARE TRUST COMPANY, N.A., as the collateral agent (in such capacity, the “Collateral Agent”).

EX-10.14·10-12G/A·CIK 1772918·ACC 0001193125-26-227113·Filed May 17, 2026, 15:01 EDT

EX-10.13

EX-10.13

EXECUTION VERSION

FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of March 30, 2026 (the “Amendment Date”), among ASP BDC LEV FACILITATION LLC, a Delaware limited liability company, as the borrower (the “Borrower”), ADAMS STREET CREDIT SOLUTIONS FUND, a Delaware statutory trust, as the servicer (in such capacity, the “Servicer”), the equityholder (in such capacity, the “Equityholder”) and the seller (in such capacity, the “Seller”), WELLS FARGO BANK, NATIONAL ASSOCIATION, as the administrative agent (in such capacity, the “Administrative Agent”) and each of the lenders from time to time party to the Loan and Security Agreement (as defined below) (together with their respective successors and assigns in such capacity, each a “Lender,” and collectively, the “Lenders”);

EX-10.13·10-12G/A·CIK 1772918·ACC 0001193125-26-227113·Filed May 17, 2026, 15:01 EDT

EX-10.1

EX-10.1

STONERIDGE, INC.

2025 LONG-TERM INCENTIVE PLAN

SPECIAL PHANTOM SHARE GRANT AGREEMENT

January 31, 2026

Stoneridge, Inc., an Ohio corporation (the “Company”), pursuant to the terms and conditions hereof, hereby grants to [[FIRSTNAME]] [[LASTNAME]] (“Grantee”) the right to receive an amount of cash equal to the value of [[SHARESGRANTED]] Common Shares, without par value, of the Company (the “Phantom Shares”). The grant of Phantom Shares (the “Award”), as embodied by this Agreement (the “Agreement”), is described below.

1.    The Phantom Shares are in all respects subject to the terms, conditions and provisions of this Agreement and Stoneridge, Inc. 2025 Long-Term Incentive Plan (the “Plan”).

EX-10.1·10-Q·CIK 1043337·ACC 0001043337-26-000052·Filed May 17, 2026, 15:01 EDT

EX-10.38

EX-10.38

- 1 - TWELFTH AMENDING AGREEMENT THIS AGREEMENT made as of the 25 day of January, 2026 B E T W E E N : JERRY ZARCONE (hereinafter referred to as “Jerry”) - and – TARGET GROUP INC. (hereinafter referred to as “TGI”) - and – CANARY RX INC. (hereinafter referred to as “Canary”) - and – VISAVA INC. (hereinafter referred to as “Visava”) - and – CANNAKORP INC. (hereinafter referred to as “Cannakorp”, which together with Visava and Canary shall be collectively referred to as the “Subsidiaries”) WHEREAS: A. Jerry and TGI entered into a Loan Agreement made as of the 20th day of December, 2019 (the “Loan Agreement”), which Loan Agreement has been amended and extended by various amending and extending agreements from time to time the most recent of is the Eleventh Amending Agreement made as of the 11th day of August, 2025 (collectively, the “FAEA”); B. All capitalized terms shall have the meanings ascribed to them in the FAEA unless otherwise defined herein; Docusign Envelope ID: 2BE13BF8-473F-450E-A95E-B7CBFCF35899

EX-10.38·10-Q·CIK 1586554·ACC 0001104659-26-062758·Filed May 17, 2026, 15:01 EDT

EX-10.2

EX-10.2

Exhibit 10.2

Securities Purchase AGREEMENT

This SECURITIES PURCHASE Agreement (this “Agreement”) is made as of May 11, 2026, by and between Tevogen Bio Holdings Inc., a Delaware corporation (the “Company”), and The Patel Family, LLP, a Delaware limited liability partnership (“Purchaser”).

For this and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

EX-10.2·10-Q·CIK 1860871·ACC 0001493152-26-023920·Filed May 17, 2026, 15:00 EDT

EX-10.1

EX-10.1

Exhibit 10.1

AMENDED AND RESTATED EXPENSE SUPPORT AND CONDITIONAL REIMBURSEMENT****AGREEMENT

This Amended and Restated Expense Support and Conditional Reimbursement Agreement (the “Agreement”) is made this 2nd day of March, 2026, by and among Third Point Private Capital Partners, a Delaware statutory trust (the “Fund”), and Third Point Private Capital LLC, a Delaware limited liability company (the “Adviser”).

WHEREAS, the Adviser and the Fund previously entered into an expense support and conditional reimbursement agreement, dated May 7, 2025 (the “Previous Agreement”);

WHEREAS, the parties hereto desire to amend and restate the Previous Agreement in its entirely and replace it with this Agreement;

WHEREAS, the Fund is a non-diversified, closed-end management investment company that intends to elect to be regulated as a business development company under the Investment Company Act of 1940, as amended (the “Investment Company Act”);

EX-10.1·10-Q·CIK 2025369·ACC 0001104659-26-062798·Filed May 17, 2026, 15:00 EDT

CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE

This Confidential Separation Agreement and General Release (“Agreement”) is made and entered into by and between Lee Fraser (“Executive”), BLC Management Company, LLC (the “Company”), and Planet 13 Holdings Inc. (“Parent”). Executive and the Company are sometimes referred to in this Agreement as a “Party” and collectively as the “Parties.”

WHEREAS it is the express intention of the Parties to fully and finally close and settle all claims, controversies, actions and disputes, whether known or unknown, which have arisen or may arise in the future relating to Executive’s employment with and subsequent separation from the Company.

WHEREAS, the Parties believe that the terms and conditions of this Agreement are fair and reasonable, and the result of an arms-length, bargained-for exchange.

EX-10.1·8-K·CIK 1813452·ACC 0001437749-26-017439·Filed May 17, 2026, 15:00 EDT

EX-10.2

EX-10.2

CONSULTING AGREEMENT

This Consulting Agreement (“Agreement”) is made as of March 18, 2026, by and between Tendler Biotech Consulting LLC, a New Jersey limited liability company with principal offices at 867 Columbus Drive, Teaneck, NJ 07666 ("Consultant") and Tuhura Biosciences, Inc a Company with principal offices at 10500 University Center Drive Suite 110 Tampa, FL 33612 ("Company").

Background:

Company is in need of support and guidance for the research, development and implementation of its biomedical products (“Company Projects”).

Consultant has expertise in the research, development and implementation of biomedical products.

Company and Consultant, in consideration of the mutual covenants herein contained, and other good and valuable consideration, receipt of which is hereby acknowledged, and intending to be legally bound agree as follows:

Section 1. Engagement; Extent of Consultant’s Services; No Restriction on other Engagements.

(a)

EX-10.2·10-Q·CIK 1498382·ACC 0001193125-26-227245·Filed May 17, 2026, 15:00 EDT

EX-10.1

EX-10.1

FIRST AMENDMENT TO LOAN AGREEMENT

This FIRST AMENDMENT TO LOAN AGREEMENT (this “Amendment”), dated as of May 15, 2026, is entered into by and among TUHURA BIOSCIENCES, INC., a Nevada corporation (“Borrower”), and PARKVIEW HOLDINGS ONE LLC, a Florida limited liability company (“Lender”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Loan Agreement referenced below.

RECITALS:

WHEREAS, Borrower and Lender are party to that certain Loan Agreement, dated as of April 21, 2026 (together with all exhibits and schedules thereto and any further amendments and modifications thereof from time to time made in accordance with the terms thereof being hereinafter referred to as the “Loan Agreement”); and

WHEREAS, Borrower and Lender desire to amend the Loan Agreement to incorporate certain terms that were agreed to between Borrower and Lender as of the Closing Date, but which, as the result of a scrivener’s error, were not reflected in the Loan Agreement.

EX-10.1·10-Q·CIK 1498382·ACC 0001193125-26-227245·Filed May 17, 2026, 15:00 EDT